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Testing the Hypothesis of a Circadian
Phase Disturbance Underlying Depressive
Mood in Nonseasonal Depression
Marijke C. M. Gordijn,1 Domien G. M. Beersma,
Henk J. Korte, and Rutger H. Van den Hoofdakker
Department of Biological Psychiatry, University Clinic, 
9700 RB Groningen P. O. Box 30.001, the Netherlands
Abstract In a crossover design, 8 nonseasonal depressed subjects, selected on the
presence of diurnal mood variations, and 8 sex- and age-matched controls were
exposed to dim light (< 10 lux) in the evening (18:00-21:00 h) and bright light
(2500 lux) in the morning (ML, 6:00-9:00 h), to dim light in the morning and bright
light in the evening (EL), or to dim light both in the evening and in the morning
(DL) during 3 consecutive days in each of these conditions. There were no initial
phase differences between depressed and healthy subjects in the timing of dim
light melatonin onset, sleep termination, and body temperature. The phase shifts
after EL and ML in both healthy and depressed subjects were as expected on the
basis of a human phase response curve. On average, there was no therapeutic
effect of the light exposure in the depressed patients. Two patients improved, but
these effects do not seem to be related to shifts in the circadian system.
Key words circadian rhythms, nonseasonal major depression, light, sleep, melatonin,
mood
INTRODUCTION
The appealing hypothesis of a causal link between
the disorganization of circadian rhythms and dis-
turbed mood in affective disorders still is open to
discussion (Van den Hoofdakker, 1994; Healy and Wa-
terhouse, 1995; Wirz-Justice, 1995). Internal dissocia-
tion of rhythms driven by the biological clock in rela-
tion to the sleep-wake cycle is one of the options,
proposed already by Papousek (1975). In the “internal
coincidence model” (Wehr and Wirz-Justice, 1981), a
causal link is postulated between a phase advance of
circadian rhythms and mood. Evidence consistent
with such a causal relationship was obtained in (un-
controlled) experimental studies on the effects of
phase-advancing sleep, relative to internal rhythms
(Wehr et al., 1979; Sack et al., 1985; Souêtre et al., 1987),
with a beneficial effect on mood. Wehr and Goodwin
(1983) reviewed evidence for a phase advance of cir-
cadian rhythms in depressives compared to healthy
controls. Since then, however, many contradictory re-
sults have been presented, for example, those re-
viewed by Checkley (1989) and Van den Hoofdakker
(1994). It is still unclear whether or not dissociated
rhythms occur during depression and, if so, whether
they are cause or effect of the mood disturbance or
whether dissociated rhythms and mood disturbance
are determined by an unknown common factor. In
addition, the question of whether disturbed rhythms
are due to a disorder of the biological clock or to
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changes in the phasing of external zeitgebers still is
unanswered (Healy and Waterhouse, 1995).
In view of the inconsistency of the evidence for the
existence and the pathogenetic significance of chrono-
biological disturbances in depression, it has been pro-
posed that such disturbances might play a role in
subgroups of depressed patients. One often men-
tioned possible indicator of chronobiological distur-
bances in depressed patients is diurnal mood vari-
ation. Recently, it has been reported that there are no
clear subgroups of patients with and without diurnal
mood variations and that the mood swings do not
commonly show a clear 24-h pattern (Gordijn et al.,
1994). However, the presence of daily mood swings,
and especially the variability thereof, is highly related
to the response to total sleep deprivation, in other
words, to a manipulation of the sleep-wake cycle.
Because of the relationship between diurnal mood
variation and the sleep-wake cycle, it is supposed that
patients with high daily mood variability are likely to
suffer from underlying chronobiological distur-
bances. This idea is supported by the results of Volz et
al. (1991); in their study, patients with diurnal vari-
ations of mood (feeling better in the evening) re-
sponded slightly better to 7 days of bright light ther-
apy in the morning than did patients without diurnal
mood variations.
The purpose of the present study is to test whether
circadian phase disturbances play a causal role in the
presence of depressive mood in a group of patients
with large daily mood variations.
Theoretically, the “cause or effect” problem can be
solved in two ways. The first possibility is to shift
circadian rhythms relative to sleep and investigate the
effects on mood. This can be achieved by exposing
subjects to light at sensitive phases of the circadian
system, that is, times at which it may be expected to
produce phase shifts. In healthy subjects, 2 or 3 days
of bright morning or evening light produced substan-
tial shifts (Czeisler et al., 1986; Dijk et al., 1987) and
amplitude changes (Jewett et al., 1991, 1994) in cir-
cadian rhythms. The second possibility to induce
phase-angle differences between circadian rhythms
and sleep is to force a sleep shift while keeping the
other clock-related rhythms unchanged. This should
be possible by controlling the light-dark cycle while
sleep time is changed. As noted earlier, phase shifts of
sleep resulted in mood changes in depressed subjects
(Wehr et al., 1979; Sack et al., 1985; Souêtre et al., 1987),
but in these studies the light-dark cycle was shifted as
well. In the present study, we chose the first procedure;
that is, subjects were exposed to bright light at particu-
lar times of the day to produce phase shifts while sleep
time was fixed.
Exposing depressive subjects to bright artificial
light is very common, especially in winter depressives,
because of the “renewed” discovery of its beneficial
effect in this group of patients (reviewed in Terman et
al., 1989). The beneficial effect of “light therapy” in
nonseasonal depressives is less clear. The effects re-
ported are controversial because most studies have
some serious drawbacks. For a recent review of the
effects of light therapy in nonseasonal depression, see
Van den Hoofdakker and Gordijn (1997). In all studies,
various times and durations of light exposure, as well
as different designs, were used. The possibility that
only a subgroup of the nonseasonal depressed pa-
tients responds favorably to light treatment is pro-
posed, but the possible predicting characteristics are
unknown. Deltito et al. (1991) reported superiority of
light in bipolar patients, Kripke et al. (1992) mentioned
a “trend for better response among bipolars,” and
Bauer (1993) reported a large beneficial effect of light
in three bipolar patients. Stewart et al. (1990) tested
whether the selection on atypical symptoms in non-
seasonals predicted response to light, but they found
no significant therapeutic effect of 2 weeks of light
therapy. Although the hypothesis of a circadian phase
disturbance underlying depression is discussed in
most of the literature, a controlled study of light expo-
sure with the purpose of shifting circadian rhythms in
nonseasonal depressives hardly ever is carried out.
Either light is given both in the morning and in the
evening (Dietzel et al., 1986; Peter, 1986; Kripke et al.,
1987, 1992) or light exposure at other sensitive phases
of the biological clock is not avoided (Deltito et al.,
1991; Bauer, 1993; Thalén et al., 1995). Obviously, both
approaches are inadequate to induce systematic shifts
in circadian rhythms. In three studies, the effects of
controlled light exposure on the depressive sympto-
matology in relation to shifts in circadian rhythms
were tested. With the exception of the case study by
Lewy et al. (1985), the two recent large studies by Rao
et al. (1992) and Yamada et al. (1995) provided no
evidence for a relationship between clinical change
and chronobiological variables. This conclusion was
based on comparisons between groups of patients, not
selected for possible predicting characteristics.
In the present study, we selected depressive sub-
jects with large diurnal mood variations. In a cross-
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over paradigm, they received either dim light both in
the morning and in the evening, dim light in the
morning and bright light in the evening, or bright light
in the morning and dim light in the evening. The
effects on circadian rhythms and mood were recorded
and compared to the effects of the same procedure in
healthy age- and gender-matched controls.
METHODS
Subjects
A total of 10 depressed patients entered the study.
Due to physical illness of 1 patient after 2 days in the
study and a change in diagnosis of another patient at
the end of the study, results are presented for 8 sub-
jects. Of these, 7 patients were outpatients and 1 was
admitted to the hospital. DSM-III-R diagnoses were
major depression (n = 7) and dysthymic disorder (n =
1). No subject reported seasonal variations in mood.
The patients were free of any use of medication, had
no major somatic disease, and did not abuse drugs or
alcohol. They showed extreme diurnal variations of
depressed mood in a 1-week observation period. Dur-
ing this week, self-ratings were completed three times
daily (9:00, 17:00, and 22:00 h) by means of the Dutch
version of Von Zerssen’s Adjective Mood Scale (AMS)
(Von Zerssen, 1976; Elsenga, 1988). The ratings range
from 56 (most severely depressed) to 0 (not de-
pressed). “Extreme diurnal variations of depressed
mood” was defined by a difference of at least 10 points
between two daily ratings on at least 3 out of 7 days.
At least one rating on these 3 days had to be higher
than 25. The decision of including a patient was made
during that selection week. Once included, every sub-
ject underwent all experimental conditions regardless
of the depression score at the start of each of these
conditions. Controls were recruited by newsletter ad-
vertisement. They were selected on having no history
of depression or any other mental illness. They had to
be physically healthy and not on medication or drugs.
Their sleep-wake behavior had to be regular without
habitual naps. After they were informed about the
experimental procedure, they were on call and noti-
fied when an appropriate depressed subject was se-
lected. Healthy subjects were matched to depressed
subjects on age and gender. Except for 2 subjects, the
healthy subjects took part in the experiment in the
same season of the year in which the depressives were
studied. The design of the experiment and the mea-
surements performed were exactly the same for both
groups. The study was approved by the ethical com-
mittee. Both depressed subjects and healthy subjects
signed written informed consents.
Design
The experimental period lasted 4 weeks. During the
first, second, and fourth weeks (further referred to as
experimental weeks), all subjects came to the labora-
tory on 4 days at 18:00 h and stayed there until 9:00 h
the next morning. The third week served as a washout
period. In this week, no laboratory visits were sched-
uled. On experimental weeks, between 9:00 and 18:00
h, subjects followed their normal daily routines; only
intensive sporting, drinking alcohol, and daytime
sleeping were not allowed. From 18:00 until 9:00 h, the
subjects stayed individually in a dimly lit room (one
15-watt light bulb, at 1 m eye distance, less than 10 lux).
During walks inside the building, they wore dark
goggles. They were allowed to read or watch televi-
sion and were visited regularly by one of the re-
searchers to prevent them from sleeping. Sleep time
was fixed from 22:00 until 6:00 h during the first 3
nights of each experimental week while lights were
off. The first week served as control with dim light
exposure (DL) both in the morning and in the evening.
During the second and fourth weeks, subjects were
exposed to bright light (2500 lux) either in the morning
(ML, 6:00-9:00 h) or in the evening (EL, 18:00-21:00 h)
on 3 consecutive days in a crossover design. In each
group, 4 subjects started in the second week with ML
and 4 with EL. The light fixtures contained 8 full-
spectrum fluorescent light tubes (Duro-lite, 40 watts)
in a light box of 110 × 120 cm placed vertically at an
eye distance of 60 cm; ultraviolet light (< 400 nm) was
filtered out. In the fourth night of each experimental
week, circadian rhythms and sleep were recorded. In
this night, subjects stayed in dim light until midnight.
At that time, they went to bed and were instructed to
sleep until spontaneous wake-up time.
Measurements
To assess the phase of the circadian pacemaker,
three variables were measured—dim light melatonin
onset (DLMO), core body temperature, and sleep tim-
ing. All these variables were obtained during the
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fourth evening and night. During this evening, with
dim light and bedtime at midnight, the direct influ-
ence of the experimental condition and related behav-
ior on the variables under study were considered to be
equal for all individuals in all conditions.
Dim light melatonin onset. To assess the DLMO,
hourly saliva samples were collected from 18:00 until
midnight while the subjects stayed in dim light (< 10
lux). No coffee or tea was served, and teeth brushing
was postponed because of the possible contaminating
effects of these substances for assessing melatonin in
saliva (Gordijn et al., 1991). Subjects were sitting in a
chair while producing the saliva to control for the
influence of posture on melatonin concentration (Dea-
con and Arendt, 1994). Limited eating, drinking, and
smoking was allowed in the first quarter of each hour,
after which the mouth was rinsed with water. Three
quarters of an hour later, saliva was collected. Imme-
diately after collection, the saliva was frozen at –20ºC
for later analysis. Melatonin was assessed by radioim-
munoassay in our laboratory. The method was, in
essentials, described by Vakkuri et al. (1984) and Vak-
kuri (1985) and was performed with [3H]melatonin.
Through the melatonin results, a sigmoid-shaped
curve was fitted using a four-parameter logistic func-
tion with the form
f(x) = 
a
1 + eb(x − c)
 + d.
DLMO was arbitrarily defined as the time when the
fitted curve exceeded a melatonin level of 20 pmol/
liter. For 3 depressed and 2 healthy subjects, it ap-
peared to be necessary to lower or increase this level
(until 10 or 30 pmol/liter) to obtain paired data for all
conditions.
Core body temperature. Core body temperature was
recorded in each experimental week during the third
and fourth night and the day in between by an ambu-
latory recording system—either a Vitalog with a sam-
ple rate of 0.25 min or a homemade three-channel
recording system (JOBLOG; Bakker and Beersma,
1991) set to a 1-min sample rate. Subsequently, each set
of four 0.25-min samples of the Vitalog system was
averaged, also resulting in a sampling interval of 1
min. Small intervals of missing data (≤ 15 min) due to
removal of the temperature probe were linearly inter-
polated. For the present analysis, the average tem-
perature per 10-min blocks was calculated from mid-
night until 7:00 h during the fourth night. The median
body temperature was calculated over this period. The
time of the midcrossing point between the first inter-
ception of decreasing body temperature with the me-
dian and the last interception of increasing body tem-
perature with the median was used as an indicator of
circadian phase.
Sleep timing. During the third and fourth nights of
each experimental week, sleep recordings were made.
Nine electrodes were attached with collodium 1 or 2 h
before bedtime (Jasper, 1958)—EEG derived from C4-
A1 and C3-A2, 2 EOG, submental EMG, and one earth
electrode on the forehead. EEG signals were digitized
with a sample rate of 128 Hz, EOG and EMG with a
sample rate of 64 Hz, and they were stored on mag-
netic tape of a micro-Vax VMS system. Afterward,
EEG, EOG, and EMG could be replayed on a 17-inch
screen, and visual scoring per 30-sec epoch according
to Rechtschaffen and Kales (1968) was performed. In
the third night, time in bed was planned from 22:00
until 6:00 h. Only wake-up time was assessed in this
night (the end time of the last page of Stage 2, 3, or 4
or rapid eye movement [REM] sleep). (Dim) Lights off
in the fourth night was set to midnight, and subjects
were instructed to sleep until they felt refreshed. Sleep
timing in the fourth night was assessed on the basis of
time of sleep onset (the start time of the first page of
Stage 2 or REM sleep) and wake-up time.
Depressed mood, various aspects of activation, and
sleep quality were assessed by multiple self-ratings
during the entire 4-week period. The Dutch version of
Von Zerssen’s AMS (Von Zerssen, 1976; Elsenga, 1988),
which measures depressed mood; the Activation-
Deactivation Adjective Checklist (Thayer, 1967),
which measures four components of activation (en-
ergy, tension, calmness, and tiredness); the Stanford
Sleepiness Scale (Hoddes et al., 1973); and a Visual
Analog Scale (VAS), which measures depressed mood,
anger, anxiety, and elation (Albersnagel, 1988), were
completed three times daily at 9:00, 17:00, and 22:00 h.
The Sleep Quality Scale (Mulder-Hajonides v.d.
Meulen et al. 1980) was completed daily at 9:00 h.
Depressed mood also was assessed with the Beck
Depression Inventory (BDI) (Beck and Steer, 1987) on
the mornings of Day 1 (the first day of EL and last day
before ML) and Day 4 (the first day after EL and last
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day of ML) of each experimental week and on the
morning of the first day of Week 6. This last BDI,
together with the BDI at Day 1 of Week 4, made it
possible to compare mood 11 days after ML with mood
12 days after EL.2 In addition, severity of depression
was assessed by the 21-item version of the Hamilton
Rating Scale for Depression (HRSD) (Hamilton, 1967).
The interview was held between 9:00 and 11:00 h on
Day 1 and Day 4 of each experimental week and was
scored by two independent, experienced raters. The
final score was calculated by averaging the scores of
the two raters. In the present study, average self-rat-
ings of mood and activation on Day 1 and Day 4 were
calculated and analyzed. Terman et al.’s (1989) criteria
for improvement after light therapy in seasonal affec-
tive disorder (> 50% reduction of the HRSD rating and
a final score of less than 8) were used to define re-
sponse. Moreover, an expectations questionnaire con-
cerning the effects on mood, general activation, anxi-
ety, and sleepiness was presented on Day 1 of each
experimental week.
Statistics
Statistical procedures included analysis of variance
(ANOVA), multiple analysis of variance (MANOVA)
with repeated measures with planned comparison for
statistical significant differences, Wilcoxon matched
pairs signed rank test, and Kendall correlations. A
probability level of  p < .05 was taken as the level of
statistical significance for all tests. Because of the small
group size (n = 8 in both groups), trends in the data
with p values between .05 and .10 also are presented.
RESULTS
Subject Characteristics
The groups consisted of 5 females and 3 males.
Average ages of depressed subjects (38.3 ± 12.2 years)
and healthy controls (38.7 ± 12.9 years) did not differ
significantly; the individual differences between pa-
tients and matched controls range from –0.7 to 1.5
years. Average severity of depression (HRSD) as mea-
sured at the first day of the DL week was 18.4 ± 3.3 in
depressed subjects and 2.1 ± 1.9 in healthy controls. In
6 of 8 cases, we managed to study the matched controls
in the same month (± 1) as the depressed subjects. The
last 2 healthy subjects were measured 6 and 4 months
later than the matched depressed subjects. Due to the
4-week duration of the experiment, it was impossible
to avoid particular phases of the menstrual cycle. We
did not control the start of the experiment for men-
strual phase.
Circadian Variables
Effects on Melatonin Profile
In healthy and depressed subjects, the profile of
melatonin concentrations after ML is shifted to an
earlier phase than after EL, whereas in the DL condi-
tion it is in between (Fig. 1, left panels). In the de-
pressed group, the melatonin concentration at 21:00 h
was significantly higher after ML than in the DL con-
dition (Wilcoxon matched pairs, p < .05). At 21:00 and
22:00 h, the melatonin concentration after ML also
was higher compared to EL, although this difference
was not statistically significant (ps = .05 and .06,
respectively). In the group of healthy subjects, there
was a significantly higher level of melatonin after
ML compared to EL at 21:00 and 22:00 h (p < .05)
and a significantly higher level after ML compared to
DL at 21:00 h. In addition, there were some differ-
ences that showed nonsignificant trends (Fig. 1, left
panels).
Curve fitting through the average curves yielded
DLMO values that confirm the interpretation that
these differences were the result of shifts of the mela-
tonin profiles. In depressed subjects, DLMO after DL
occurred at 21:08 h, after EL at 21:55 h, and after ML at
20:24 h. In healthy subjects, DLMO values were 21:24 h,
after DL, 21:49 h after EL, and 19:55 h after ML. A
comparison of the melatonin profiles in depressed
subjects with the profiles in healthy subjects yielded
no significant differences in all three conditions
(Fig. 2, upper panels). This means that the effects of
the three lighting conditions on the melatonin profiles
were not different between depressed and healthy
subjects.
Next, we compared the two most extreme condi-
tions with respect to the timing of melatonin—the ML
and EL conditions within individuals. The compari-
son of DLMO after EL and ML was possible in 6
2. The 1-day difference is due to the fact that ML is given
from Tuesday until Thursday, whereas EL is given from
Monday until Wednesday.
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healthy and 7 depressed subjects; in the other subjects,
melatonin concentrations were so low that DLMO
could not be determined reliably in one or both condi-
tions. In 4 depressed and 4 healthy subjects, the
melatonin level of 20 pmol/liter was used as a crite-
rion to assess DLMO; in 1 depressed and 1 healthy
subject, a higher criterion level was necessary; and in
2 depressed subjects and 1 healthy subject, a lower
level was used. Because the criterion level for DLMO
differed between subjects, the absolute times of
DLMO after EL and ML cannot be compared across
individuals.
The shifts of DLMO after ML compared to EL were
in the expected direction in all individuals; the onsets
after ML were earlier than those after EL (Fig. 3, left
panels). On average, in healthy subjects, DLMO after
ML started 87 min earlier than after EL (p < .05, Wil-
coxon test); in depressed subjects, it started 85 min
earlier after ML than after EL (p < .05).
Effects on Sleep Variables
Wake-up times in the third night did not differ
significantly between conditions or between groups
Figure 1. Profiles of melatonin concentration in saliva during the evening after various lighting conditions in depressed (n = 8) and
healthy (n = 8) subjects (left panels) and accumulation of wakefulness after sleep onset during the night after various lighting conditions
in depressed (n = 8) and healthy (n = 7) subjects (right panels). Statistics (Wilcoxon matched pairs): +p < .10, *p < .05, indicated at the
appropriate times.
Gordijn et al. / NONSEASONAL DEPRESSION     137 
 at University of Groningen on February 11, 2010 http://jbr.sagepub.comDownloaded from 
(patients: DL = 5:58 h ± 5 min, EL = 5:53 h ± 14 min,
ML = 5:50 h ± 28 min; controls: DL = 5:56 h ± 15 min,
EL = 5:48 h ± 35 min, ML = 5:59 h ± 4 min).
During 1 registration night (fourth night), all elec-
trodes were torn loose by 1 of the healthy subjects. For
this reason, the precise wake-up time according to the
EEG measures is missing in 1 night after ML. How-
ever, times of lights off and sleep onset are available.
Also, spontaneous rising time is known. Because in
this individual’s other 2 registration nights there were
only 2 and 21⁄2 min, respectively, between wake-up
time and rising time, an estimate of wake-up time was
derived by subtracting 2 min from rising time in the
night under consideration.
No statistical main effect (MANOVA with repeated
measurements, two factors, two and three levels, re-
spectively) between depressed and healthy subjects
was found for the sleep variables presented (Table 1).
Figure 2. Profiles of melatonin concentration in saliva during the evening after various lighting conditions in depressed (n = 8) and
healthy (n = 8) subjects (upper panels) and accumulation of wakefulness after sleep onset during the night after various lighting conditions
in depressed (n = 7) and healthy (n = 7) subjects (lower panels). +p < .10.
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Times of lights off were the same for both groups in all
conditions, as was intended. There was a significant
Group × Condition interaction effect for sleep onset
time (p < .05). Planned comparison yielded a signifi-
cant difference between controls and patients in sleep
onset after ML compared to DL; patients showed an
earlier sleep onset after ML compared to DL, whereas
controls showed the opposite (p < .05). Controls
showed a trend in earlier sleep onset after EL com-
pared to ML where patients showed the opposite (p = .06).
The largest difference, however, is found in wake-up
times. A significant main effect for condition was
found, but no interaction effect was found.  On aver-
age, wake-up time after ML was 78 min earlier than
wake-up time after EL in depressed subjects and 50
min earlier in healthy subjects. Wake-up time in DL
was situated in between, but was not significantly
different from, wake-up times after both ML and EL.
The right panels in Fig. 1 present the average accu-
mulation of “wakefulness after sleep onset” in the
three conditions. This figure suggests that the ten-
dency for sleep termination speeds up earlier after ML
than after EL (significantly different at 9 and 10 h since
sleep onset in patients, p < .05, and at 6, 8, 9, and 10 h
since sleep onset in controls). The data for DL are in
between. During the first hour of sleep, controls were
Figure 3. Timing of dim light melatonin onset, sleep termination, and time of temperature midpoint after 3 days of evening light and 3
days of morning light in depressed (n = 8) and healthy (n = 8) subjects. Paired data from individual subjects are interconnected by straight
lines; unpaired data are shown by symbols only. Left panels: individual melatonin levels were used to obtain paired data: l{ level = 20
pMol/liter, n level = lower than 20 (10 or 15) pMol/liter, s∆ level = higher than 20 (25 or 30) pMol/liter. Middle panels: *estimated
wake-up time (see text). Right panels: time of temperature midpoint, defined as the midpoint between downward and upward crossing
of body temperature through the median value.
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significantly less awake after EL than after DL, but the
difference was very small (5.5 min).
After DL and ML, the accumulation of wakefulness
slightly differs between patients and healthy subjects
(Fig. 2, lower panels). After DL, healthy subjects
showed a few minutes more wakefulness after 3, 4, 7,
and 9 h since sleep onset (n = 7, p < .10). After ML, the
accumulation of wakefulness increased earlier in
healthy subjects after 7, 8, 9, and 10 h since sleep onset
(n = 7, p < .10). The accumulation of wakefulness after
EL was not significantly different.
The individuals’ wake-up times after EL and ML
are presented in the middle panels of Fig. 3. In the
group of depressed subjects, wake-up times were later
after EL than after ML in all 8 subjects. In the group of
healthy subjects, 1 subject showed later wake-up time
after ML than after EL; the data of the other 7 subjects
confirmed the expectations.
Effects on Body Temperature
Unfortunately, several registrations of body tem-
perature are missing, mainly due to improper posi-
tioning of the temperature probe. Therefore, the re-
sults have to be interpreted with caution. The right
panels of Fig. 3 represent the phase of the midpoint
between downward and upward crossing of body
temperature through the median value in individuals
after EL and ML. In both depressed subjects (n = 4) and
healthy subjects (n = 6), the timing of this midpoint
was later after EL than after ML. ANOVA with re-
peated measurements revealed no significant differ-
ence between the two groups (difference between ML
and EL: in depressed subjects, 70 min; in healthy sub-
jects, 30 min, n.s.). However, there was a significant
difference between lighting conditions; the phase of
the temperature midpoint was significantly earlier
after ML compared to EL in the group of healthy
subjects (30 min, n = 6, F = 28.07, p < .01) as well as in
the combined group of depressed and healthy subjects
(41 min, n = 10, F = 12.29, p < .01).
Finally, we examined the interrelationship between
the shifts of the three variables—DLMO, wake-up
time, and body temperature midcrossing. Linear re-
gression revealed no significant intercorrelations (de-
pressed and healthy subjects combined, n ranges from
7 to 13).
Effects on Mood and Activation
Tables 2 and 3 present the average scores of the self-
ratings and the HRSD on Day 1 and Day 4 in the
depressed and healthy subjects.
Except for the ratings on the VAS for “anger,” the
depressed subjects differed significantly from the
healthy subjects on all ratings (ANOVA). MANOVA
with repeated measurements was carried out within
groups.
Within the group of depressed subjects, MANOVA
revealed only one significant main effect for the factor
“Day 1/Day 4”; this means that the HRSD ratings at
Day 4 were lower compared to those at Day 1. No
significant interaction effect was found. Thus, the
magnitude of the reduction in HRSD ratings (2.2
points on average) did not differ between conditions.
Also, no differences between conditions were ob-
served when we tested the HRSD ratings at Day 4 of
each condition with the HRSD ratings at Day 1 as a
covariate; this means that there was no difference in
severity of depression at Day 4 between conditions if
Table 1. Effects (± SD) on sleep variables (mean hours and minutes ± min) in the fourth night after 3 days of different light exposures.
Depressed Subjects Healthy Subjects
Sleep Variable DL ML EL DL ML EL
Lights off 00:05 ± 3 00:05 ± 5 00:06 ± 7 00:06 ± 5 00:08 ± 8 00:08 ± 8
Sleep onseta 00:21 ± 10 00:14 ± 9 00:19 ± 11 00:17 ± 7 00:21 ± 8 00:18 ± 8
Wake-up timeb 08:31 ± 88 07:44 ± 42 09:02 ± 54 07:39 ± 87 07:30 ± 86 08:20 ± 72
NOTE: DL = dim light (< 10 lux 18:00-21:00 h and < 10 lux 6:00-9:00 h); ML = morning light (< 10 lux 18:00-21:00 h and 2500 lux 6:00-9:00 h);
EL = evening light (2500 lux 18:00-21:00 h and < 10 lux 6:00-9:00 h). Multiple analysis of variance with repeated measurements (Factor 1: subject
group, 2 levels; Factor 2: condition, 3 levels, Wilks’s lambda), n = 8 in both groups.
a. Significant interaction effect: Group versus Condition, p < .05—Group × DL-ML, F(1, 14) = 7.79, p < .05; Group × ML-EL, F(1, 14) = 4.26,
p = .06.
b. Main effect of condition, p < .001: ML-EL, F(1, 14) = 19.61, p < .001.
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Table 2. Average (± SD) mood ratings in depressed subjects 1 day before (Day 1) and 1 day after (Day 4) 3 consecutive days of (dim) light
exposure.
            DL            ML             EL
   Day 1    Day 4    Day 1     Day 4    Day 1    Day 4
AMS depression 36.5 ± 8.6 32.0 ± 13.5 29.5 ± 12.9 27.9 ± 14.7 29.9 ± 16.7 32.2 ± 12.4
AD-ACL energy 8.1 ± 1.5  9.6 ± 2.7  9.5 ± 2.4 10.9 ± 2.4 10.3 ± 3.3 10.1 ± 1.3
AD-ACL tiredness 15.4 ± 3.0 14.2 ± 2.7 14.8 ± 2.6 14.4 ± 2.2 14.0 ± 2.4 14.4 ± 1.5
AD-ACL tension 12.0 ± 2.2 11.7 ± 1.8 11.4 ± 2.6 11.1 ± 2.2 11.2 ± 1.7 12.2 ± 1.8
AD-ACL calmness 13.1 ± 1.8 13.0 ± 1.9 13.6 ± 2.5 14.0 ± 2.2 12.9 ± 1.2 12.9 ± 1.6
SSS sleepiness 4.1 ± 0.7 3.4 ± 0.7 3.4 ± 0.7 3.4 ± 0.6 3.3 ± 1.0 3.5 ± 0.4
SQS sleep quality 8.5 ± 2.8 6.5 ± 4.4 6.8 ± 4.3 5.0 ± 3.1 6.1 ± 4.3 6.3 ± 3.9
VAS anxiety 33.8 ± 20.4 32.9 ± 12.4 28.0 ± 13.9 25.1 ± 17.3 30.9 ± 17.0 32.8 ± 15.5
VAS anger 8.5 ± 11.0 8.2 ± 9.1 12.6 ± 14.9 18.5 ± 18.8 12.1 ± 13.3 18.3 ± 19.7
VAS depression 49.3 ± 18.7 43.5 ± 26.2 36.4 ± 27.7 39.8 ± 31.0 39.5 ± 26.6 41.2 ± 21.9
VAS elation 26.0 ± 10.0 31.8 ± 13.8 39.8 ± 13.8 37.4 ± 20.0 37.1 ± 17.0 35.1 ± 9.6
BDI depression 18.3 ± 8.6 15.6 ± 9.1 14.5 ± 7.6 13.6 ± 11.3 14.4 ± 8.3 16.4 ± 11.1
HRSD depressiona 18.4 ± 3.3 13.6 ± 3.6 14.8 ± 4.7 14.3 ± 5.9 16.2 ± 5.7 15.0 ± 4.6
NOTE: DL = dim light (< 10 lux 18:00-21:00 h and < 10 lux 6:00-9:00 h); ML = morning light (< 10 lux 18:00-21:00 h and 2500 lux 6:00-9:00 h);
EL = evening light (2500 lux 18:00-21:00 h and < 10 lux 6:00-9:00 h). MANOVA with repeated measurements (Factor 1: condition, 3 levels,
Wilks’s lambda; Factor 2: Day 1/Day 4, 2 levels). AMS = Adjective Mood Scale; AD-ACL = Activation-Deactivation Adjective Checklist; SSS =
Stanford Sleepiness Scale; SQS = Sleep Quality Scale; VAS = Visual Analog Scale; BDI = Beck Depression Inventory; HRSD = Hamilton Rating
Scale for Depression.
a. Main effect factor: Day 1/Day 4, F(1, 7) = 21.88, p < .01.
Table 3. Average (± SD) mood ratings in healthy subjects 1 day before (Day 1) and 1 day after (Day 4) 3 consecutive days of (dim) light exposure.
            DL            ML             EL
   Day 1    Day 4    Day 1     Day 4    Day 1    Day 4
AMS depressiona 5.6 ± 3.2 3.9 ± 3.8 3.5 ± 3.7 5.3 ± 5.3 4.0 ± 4.1 5.7 ± 6.2
AD-ACL energy 16.2 ± 2.6 17.0 ± 3.2 17.0 ± 3.1 16.6 ± 3.4 16.5 ± 3.1 16.0 ± 3.7
AD-ACL tiredness 9.8 ± 2.4 8.6 ± 2.8 8.7 ± 3.0 8.9 ± 3.6 9.0 ± 3.2 9.3 ± 3.4
AD-ACL tension 7.4 ± 2.0  7.2 ± 2.3 7.4 ± 2.8 7.9 ± 3.5 7.1 ± 2.8 7.3 ± 3.5
AD-ACL calmness 16.2 ± 1.6 15.9 ± 1.3 16.0 ± 1.5 16.3 ± 1.8 16.5 ± 1.8 16.3 ± 1.8
SSS sleepiness 2.3 ± 1.2 1.6 ± 0.6 1.5 ± 0.5 1.6 ± 0.6 1.8 ± 0.8 1.8 ± 0.6
SQS sleep quality 2.3 ± 1.9 1.9 ± 1.9 1.0 ± 1.1 2.3 ± 2.9 2.0 ± 2.3 3.0 ± 3.1
VAS anxietyb 13.9 ± 12.3 7.5 ± 8.4 6.6 ± 9.6 6.6 ± 8.7 5.2 ± 7.7 4.7 ± 7.0
VAS anger 11.1 ± 11.5 5.9 ± 6.6 5.3 ± 6.5 4.4 ± 4.8 4.0 ± 5.3 3.3 ± 7.0
VAS depression 15.1 ± 14.3 7.5 ± 6.8 5.5 ± 7.8 6.1 ± 7.2 5.2 ± 5.7 6.8 ± 6.2
VAS elationc 64.4 ± 14.8 73.6 ± 17.2 77.2 ± 16.8 74.1 ± 19.6 71.0 ± 16.4 71.1 ± 17.6
BDI depression 1.4 ± 1.5 2.0 ± 3.2 0.3 ± 0.5 1.0 ± 1.2 0.1 ± 0.4 0.6 ± 0.9
HRSD depression 2.1 ± 1.9 1.8 ± 1.2 1.4 ± 1.6 2.3 ± 1.8 1.5 ± 1.3 2.3 ± 1.5
NOTE: DL = dim light (< 10 lux 18:00-21:00 h and < 10 lux 6:00-9:00 h); ML = morning light (< 10 lux 18:00-21:00 h and 2500 lux 6:00-9:00 h);
EL = evening light (2500 lux 18:00-21:00 h and < 10 lux 6:00-9:00 h). MANOVA with repeated measurements (Factor 1: condition, 3 levels,
Wilks’s lambda; Factor 2: Day 1/Day 4, 2 levels). AMS = Adjective Mood Scale; AD-ACL = Activation-Deactivation Adjective Checklist; SSS =
Stanford Sleepiness Scale; SQS = Sleep Quality Scale; VAS = Visual Analog Scale; BDI = Beck Depression Inventory; HRSD = Hamilton Rating
Scale for Depression.
a. Significant interaction effect: Condition versus Day 1/Day 4, p = .05—DL-ML/day, F(1, 7)= 11.61, p < .05; DL-EL/day, F(1, 7) = 9.22, p < .05.
b. Main effect of condition, p < .05: DL-ML, F(1, 7) = 9.77, p < .05; DL-EL, F(1, 7) = 13.70, p < .01; ML-EL, F(1, 7) = 5.58, p = .05. Main effect of
Day 1/Day 4, p = .05. Significant interaction effect: Condition versus Day 1/Day 4, p = .05—DL-ML/day, F(1, 7) = 10.92, p < .05; DL-EL/day,
F(1, 7) = 11.41, p < .05.
c. Main effect of condition, p < .05: DL-ML, F(1, 7) = 8.94, p < .05; ML-EL, F(1, 7) = 5.97, p < .05.
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controlled for possible differences in severity of de-
pression at Day 1. Not one of the self-ratings differed
between conditions or from Day 1 to Day 4. BDI rat-
ings 11 days after ML were not significantly different
from BDI ratings 12 days after EL (not in Table 2 [1 BDI
missing]), BDI ratings 11 days after ML (15.9 ± 9.0)
were not significantly different (1 BDI missing, n = 7,
n.s.) 12 days after EL (13.4 ± 6.3).
Observation of the individual data revealed 1 sub-
ject who was improved after the DL condition and 1
who was improved after the ML condition, according
to HRSD criteria—a pre-post difference > 50% and a
final rating < 8. Both subjects remained rather well
over the subsequent light conditions—HRSD ratings
of 10 before and 8 after ML and 9 before and after EL
in the first subject and HRSD ratings of 9 before and
11.5 after EL in the second subject.
Within the group of healthy subjects, some signifi-
cant differences were found. Planned comparison af-
ter the significant interaction effect in the AMS depres-
sion ratings revealed that the decrease after DL
differed significantly from the increase after ML and
from the increase after EL (for significance, see Table 3).
However, the raw data show that the scores are quite
different from those of the depressed subjects. Depres-
sive mood increased only slightly, and the scores after
ML and EL are comparable with the values before DL.
Anxiety differed significantly between all conditions.
The highest values were found before and after DL
and the lowest before and after EL, with the ratings
before and after ML in between. Anxiety decreased
significantly over the experimental weeks and
showed a significant interaction effect. The decrease of
anxiety after DL was largest compared to the decrease
after EL and the absence of change after ML. Elation
ratings differed only between conditions, with slightly
higher ratings before and after ML than before and
after DL and EL.
Summarizing the effects of morning and evening
light, in depressive subjects there is no effect on any of
the self-rating variables, whereas in healthy subjects
there is a minor difference (i.e., elation and anxiety are
somewhat higher before and after ML than before and
after EL).
The overall subjective expectation at the beginning
of the experimental weeks did not differ between the
three conditions, both for depressed subjects and for
healthy subjects. There was a trend in healthy subjects
of a different expectation of ML effects compared to EL
effects (p = .06). This difference was caused mainly by
the expectation to become more sleepy by EL.
Relationship between Mood and Circadian Phase
The question of whether there is a direct relation-
ship between mood and circadian phase is difficult to
answer. Although all three variables showed shifts in
the same direction after EL compared to ML, the mag-
nitude of the shifts differed. This resulted in the ab-
sence of significant interrelationships. Therefore, it is
unclear which variable should be chosen as a marker
of circadian phase. In addition, the group size (n = 8)
is too small to justify a statistical approach.
However, it is interesting to observe the phase shifts
in the 2 subjects who were improved, 1 after the ML
condition and 1 after the DL condition. The first sub-
ject, who had received ML as the first condition after
DL, showed a relatively large phase advance of wake-
up time (94 min earlier than after DL) but shifted back
completely after EL (wake-up time 4 min later than
after DL) without deterioration of mood. DLMO in
this subject showed phase delays after ML (–41 min)
as well as after EL (–148 min) relative to the phase after
DL. Unfortunately, the phase of the body temperature
rhythm could not be determined after ML. The second
subject who was improved after DL showed phase
delays in wake-up time both after EL (–77 min, the first
condition after DL) and after subsequent ML (–21 min)
relative to the phase after DL without deterioration of
mood. DLMO was not shifted after EL compared to
DLMO after DL but shifted in advance after ML com-
pared to DL (+43 min). The phase of the body tempera-
ture rhythm showed a large phase delay after EL
compared to the phase after DL (–175 min) and also a
phase delay after ML relative to the phase after DL
(–91 min).
DISCUSSION
Limitations of the Study
The aim of this study was to determine whether
circadian phase disturbances play a role in the patho-
genesis of depressive mood. To induce a clear shift in
circadian rhythms, 3 days of bright light exposure at
the appropriate time of day, while preventing light
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exposure during the other sensitive parts of the phase
response curve, are sufficient in healthy subjects
(Czeisler et al., 1986; Dijk et al., 1987). Light therapy
induces quick mood changes in seasonal affective dis-
orders in about the same time span (3-5 days)
(Meesters et al., 1995), although longer treatment du-
rations have been reported to result in further im-
provement (Bauer et al., 1994; Labbate et al., 1995).
Usually, improvement of nonseasonal depressive pa-
tients takes far more time. For instance, pharmacologi-
cal treatment with tricyclic antidepressives takes at
least 3 weeks to induce therapeutic effects. On the
other hand, also in nonseasonal depressives, fast im-
provement is actually possible as demonstrated by the
immediate effects of total sleep deprivation (for a re-
cent review, see Van den Hoofdakker, 1994). In the
course of our study, it became clear that the overall
responses of our nonseasonal depressed patients to
the short-lasting light conditions were clinically neg-
ligible. Moreover, data were being published suggest-
ing that in those cases in which nonseasonal depres-
sives were reported to benefit from light therapy,
longer periods of treatment were used (Kripke et al.,
1992; Rao et al., 1992; Wetterberg, 1992). For those
reasons, we limited the study to 8 patients. This small
group size raises the possibility of insufficient power
to detect differences. The strong point of the present
study is that it is a within-subjects comparison, in
contrast to the between-subjects comparison of two
other studies that examined clinical change in relation
to chronobiological variables (Rao et al., 1992; Yamada
et al., 1995). In this context, the present study might
play a role in the discussion on the possible pathoge-
netic role of circadian phase disturbances in depression.
Effects on Circadian Rhythms
The time courses of the three physiological variables—
DLMO, core body temperature, and sleep termination—
are supposed to be under the control of the circadian
pacemaker. After DL, no clear differences in phase
positions of these variables were found between
healthy and depressed subjects. This result does not
indicate an abnormal phase position of the biological
clock in our sample of depressives. The accumulation
of wakefulness after sleep onset differs between de-
pressives and controls after DL and ML, but these
differences were significant only at a level of p < .10
and were observed not only at the end of the night but
also at various times during the night (after DL).
Therefore, we do not interpret this finding as an indi-
cation of a different phase position. Controls were
slightly more awake than depressives. Because sleep
disturbances normally are found in depressive pa-
tients, this result seems contradictory to what would
be expected. However, our depressive subjects did
not, on average, report severe sleep complaints.
In general, both in the healthy subjects and in the
patients, the phase shifts brought about by EL and ML
were as expected on the basis of our knowledge of the
human phase response curve. Phase positions were
assessed at the end of each condition only. According
to empirical (Czeisler et al., 1986; Minors et al., 1994)
and simulated data (Daan and Beersma, 1992), the
washout period of 11 to 12 days in between ML and
EL was considered to be long enough to recapture
baseline phase positions at the start of the next condi-
tion. Not 1 subject showed an unexpected phase shift
of DLMO after bright light exposure. The average
melatonin profile after EL shifted –47 min with respect
to DL in depressed subjects and –25 min in healthy
subjects. After ML, the average melatonin profile
shifted +44 min in depressed and +89 min in healthy
subjects with respect to DL. Also, the timing of the
body temperature rhythms after EL and ML was as
expected. With respect to the timing of sleep termina-
tion in the fourth night, there was only 1 healthy
subject with a later wake-up time after ML compared
to EL; all other subjects, both healthy and depressed,
woke up earlier after ML than after EL. The conclusion
must be that the circadian rhythms studied showed
quite normal reactions to EL and ML in both healthy
and depressed subjects. Yamada et al. (1995) obtained
similar conclusions, although in their study the shifts
were somewhat larger in patients than in controls.
Wake-up time in the third night was not different
between groups. Therefore, we conclude that we in-
duced phase relation differences between circadian
rhythms and sleep in the third night, and probably in
all 3 nights, as we intended.
Between variables, there were some differences in
the magnitude, and occasionally in the direction, of
the shifts, and they were not significantly correlated.
If rhythms were not completely entrained after 3 days,
this still can be understood to be caused by one pace-
maker (Daan and Beersma, 1992). However, Shanahan
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and Czeisler (1991) reported that 3 days with light
exposure induced equivalent shifts in melatonin
rhythm and core body temperature rhythms in a con-
stant routine protocol the next day. The discrepancy
between these authors’ data and ours most likely is
explained by the small group size in our study and the
noise in our data induced by the “semi-naturalistic”
experimental circumstances; our temperature data are
not recorded in a constant routine protocol and, con-
sequently, were influenced by sleep and activity. Nev-
ertheless, this means that within individuals, shifts of
various variables can differ between each other. Over-
all, the observed shifts in DLMO, sleep termination,
and body temperature seem robust and in line with
theoretical predictions. For this reason, the shifts are
interpreted as valid indicators of shifts of the circadian
pacemaker.
Effects on Mood and Activation
Except for anger, the average mood and activation
ratings of depressed subjects differed from those of
healthy subjects. This means that the 2 groups were in
quite different mood states at the start of the experi-
ment (as was intended) as well as during the experi-
mental weeks.
On average, the group of depressed subjects did not
benefit from the various light conditions, although
there were 2 individuals who clearly improved during
the 4 weeks. The only significant overall effect was a
slight decrease in depression, as measured with the
HRSD, during the experimental weeks regardless of
whether it was measured after EL, ML, or DL. This
decrease was only minor and without substantial
clinical relevance. An explanation of these mood
changes in terms of effects of shifts in circadian
rhythms is not very plausible. If a shift in circadian
rhythms would be the mechanism underlying the
mood changes, then one would expect that these
changes would be different, even opposite, for the ML
and EL conditions. The effects on the HRSD ratings,
however, were similar regardless of the type of treat-
ment. The positive responses of the 2 individuals after
DL and ML, respectively, were not reversed in the
subsequent conditions despite the concomitant shifts
(both advances and delays) of the three physiological
variables. In our opinion, there is no plausible expla-
nation for the minor mood changes observed over the
conditions other than in terms of placebo mechanisms
or spontaneous temporal fluctuations. The finding
that the largest improvement occurred during the first
week with DL probably is due to the high ratings at
the start of the experiment, possibly caused by initial
unacquaintedness with the situation. Because we ana-
lyzed many mood factors, both self-ratings and the
HRSD, it is remarkable that not more mood measure-
ments turned out to be significantly different just by
chance.
In the group of healthy subjects, there were a num-
ber of significant changes in self-ratings. These effects
are mainly interaction effects and attributable to the
relatively large change after DL. For instance, the de-
crease in depression rating (AMS) after DL differed
from the increase after EL and ML. These “increases,”
however, are very small and not clinically relevant.
The healthy subjects did not become really “de-
pressed.” In the elation and anxiety ratings, there were
significant main effects of condition. Again, this is
caused mainly by high anxiety and low elation ratings
at the start of the experiment. Just as seems the case
with the depressed subjects, inclusion in the experi-
mental procedure caused high ratings at the start and
a rapid decline after DL. There also are minor differ-
ences in anxiety and elation ratings between ML and
EL regardless of whether it was at the start or the end
of the experimental weeks, with both variables being
somewhat higher both before and after ML. This sug-
gests that healthy subjects, although somewhat more
anxious, liked the ML condition more than the EL
condition. The tendency of a different expectation of
the effects of ML compared to EL—the expectation of
becoming more sleepy due to the EL condition—is in
agreement with this interpretation, although there are
no actual significant effects on sleepiness ratings.
Depressive Mood and Circadian Rhythms
In earlier studies, we found that the response to
total sleep deprivation is strongly related to the pres-
ence and variability of diurnal mood variations (Rein-
ink et al., 1993; Gordijn et al., 1994). One interpretation
might be that patients with diurnal mood variations
are those with chronobiological disturbances. Sleep
deprivation effects in this reasoning might be ex-
plained by avoiding the coincidence of sleep with a
particular phase of the circadian system (Wehr and
144      JOURNAL OF BIOLOGICAL RHYTHMS / April 1998
 at University of Groningen on February 11, 2010 http://jbr.sagepub.comDownloaded from 
Wirz-Justice, 1981). An alternative interpretation is
that manipulation of the sleep-wake cycle can act as a
mood-changing stimulus for those subjects who are
highly susceptible to stimuli in general, reflected in
diurnal mood variability (Gordijn et al., 1994) and
variability in the sleep deprivation effect (Gordijn et al.,
1995). Both interpretations predict that patients’ mood
may be changed by manipulations of the circadian
system by light. This idea was supported by data of
Volz et al. (1991), who reported a small predictive
value of diurnal mood variation with respect to the
success of light therapy.
The results from the present study do not indicate
circadian phase abnormalities in this group of depres-
sives. This finding supports most of the recent data
from other studies (for reviews, see Checkley, 1989;
Van den Hoofdakker, 1994; Wirz-Justice, 1995) but
now for a selected group of depressives with diurnal
mood variations. Second, the shifts of the circadian
rhythms measured in this study, induced by light ex-
posure, were not different between depressives and
controls. This indicates that not only the phase posi-
tion but also the sensitivity of the biological clock to
light probably is not different between depressives
and controls. Furthermore, there is no indication of
any relationship between a mood change and an in-
duced phase relation difference (1-2 h) between cir-
cadian rhythms and sleep. The result that opposite
phase shifts within the same subject do not result in
opposite mood changes strengthens the conclusion
that no clear relationship between shifts of the cir-
cadian system and mood exists in the present group
of depressives and healthy subjects. This is the third
study that concludes that the possible effects of light
in nonseasonal depressives are not mediated by
chronobiological mechanisms (Rao et al., 1992;
Yamada et al. 1995). Alternative explanations for the
lack of a mood change in the present study are that the
phase shifts induced were too small to obtain effects
or that the duration of the shifts did not last long
enough. It must be mentioned, however, that 1 night
of sleep deprivation can have immediate large effects.
In summary, a subgroup of nonseasonal depressive
subjects characterized by large diurnal mood vari-
ations turned out to be insensitive to short-lasting
moderate phase shifts of the circadian system relative
to sleep phase. The phase shifts induced by light were
not different from the phase shifts achieved in healthy
controls. This suggests that the sensitivity of the bio-
logical clock to light is not different between depressives
and controls. In contrast to sleep deprivation, moder-
ate shifts of circadian rhythms do not act as mood-
changing stimuli. The present results do not plead for
an important role of circadian phase disturbances un-
derlying depressive mood in depressive illness.
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